04.03.2014 • News

Challenges Facing the Pharmaceutical Industry

The webinar "Challenges Facing the Pharmaceutical Industry" organized by ChemistryViews.org will take place on Thursday March 27, 2014 at 8:00 PDT | 11:00 EDT | 15:00 UK | 16:00 CET.

John LaMattina, former President, Pfizer Global R&D, discusses how and why the pharma industry is devalued and distrusted.

Topics covered in the webinar are:
a) Challenges facing the industry: establishing the safety AND value of new drugs;
b) Issues facing the Industry on its reputation;
c) A prescription form restoring its reputation.

John La Mattina is a Senior Partner at PureTech Health and author of the books:
Drug Truths: Dispelling the Myths About Pharma R&D and Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image?

Please follow this link to register for the webinar.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.